chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I am a 63-year-old male. I received the Moderna vaccination. I noticed my issue about 4 weeks after my second shot.  I also had my second shingle shot 4 weeks after my second Moderna.  I went to my primary Doc and he basically laughed and said he had never heard of tinnitus as a side effect. My Doc sent me to the ENT Doc. The ENT said the same as my Primary Doc. The ENT doc sent me to an Audiologist. The Audio Doc said I had great hearing with just a little high note hearing loss. The Audio Doc informed me that hearing has nothing to do with tinnitus, it has something to do with the brain. The Audio Doc told me she has about seven new patients complaining about tinnitus.  The Audio Doc recommended an app to listen to and all my research said it would not help, only make you think of something else. She informed me to notify the CDC with my issue.  I sent a note with my regular Vaers report and never got any response.   I got my Moderna booster shot on December 12, 2021 and my tinnitus got louder.  I googled remedies and have been taking Silencil for the past month and have not noticed any change. They said it should help within 30 days and may need to take as long as 180 days. It seems that my tinnitus has gotten worse. I do notice while I am working the noise is softer because of me concentrating on something else. It is loudest at nighttime and prior to falling asleep. My research found tinnitus is the cause of nerves in the brain that are short-circuiting and generating the noise.
I woke up the next morning after receiving the vaccination with very severe pain to my right arm. It was deep in my arm pit (axillary region).  Painful lymph nodes in that area. General fatigue and aches progressed throughout the day as well. But the arm pit/ breast pain was very severe!
Extreme (3" x 3") swelling, redness, itching, warmth and hardness at injection site. On my back I had two raised spots (1" x 1") that were red, itched, and developed a small scab. Both sites lasted ten days however my arm (larger spot) is still sore and somewhat discolored.
Patient with COVID x 3 days after being fully vaccinated.  Received mAB infusion for COVID infection then developed worsening confusion and weakness afterwards.
Chills began the day after vaccination 2 days after vaccination a large, red, itchy, hot and painful lump at injection site that continues to spread and is currently the diameter of a baseball at 5 days post vaccination.
my left arm has a round red rash the size of a large orange, a little hard to touch, feel warm and is sore to touch
Information has been received from a nurse concerning a female who was vaccinated with a dose of GARDASIL on an unspecified date at a University Student Health Center. No specific provider information was available. Subsequently the patient developed seizures after vaccination. No other symptoms or treatment reported. At the time of the report, the outcome of seizures was unknown. Upon internal review, seizures were determined to be an other important medical event. Additional information has been requested.
Extreme Persistent Fatigue despite adequate rest, weakness, weight loss, brain fog, difficulty concentrating/attention, headaches, GI disturbances.
pt recv vax 30OCT98 & devel Bells Palsy lt 8NOV98;
Day after shot was given, her legs started teitching.  The doctor told me this was normal.  It kept up, got worse where she would turn blue, eyes bulged out and body folding in half.  She is now 9 and has epilepsy and cerebral palsy.  She has to take a total of 21 pills each day, which does not stop her seizures, it only makes then not as strong sometimes.  She is completely disabled.  Never has spoken, crawled or walked.  Has been dependant on us for everything since this shot.  4/22/09  Lengthy medical record received including multiple admissions and outpatient consultations-2000-2008. Pt first presented with myclonic seizures resembling infantile spasms/jerking of extremities in 12/1999. Multiple admissions with dx of Myoclonic Seizure Disorder. Later dx of Progressive Myoclonic Dystrophy, CP, refractory seizure d/o, and global developmental delays. Other dx: bradycardia, failure to thrive, gastroparesis with delayed gastric emptying, hearing loss, static encephalopathy, spastic quadriparesis of CP.  Most recently admitted with dx: Epilepsy-increased seizure activity.  At age 8yrs has developmental age of 9 months.`
Pt experienced fever, headache and general malaise after receiving 2nd dose of Imovax. Followup 09/30/98 reported pt recovered.
This case was reported by a nurse to sales representative and described the occurrence of limb swelling in a subject of unspecified age and gender who was vaccinated with diphtheria and tetanus toxoid and acellular pertussis vaccine adsorbed (Infanrix, GlaxoSmithKline) for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were not reported. On an unspecified date in June 2006, the subject received a dose of Infanrix (lot number and dose number were not reported) at an unspecified site of administration. On an unspecified date on or before 27 June 2006 after vaccination with Infanrix, the subject experienced limb swelling and redness. The outcome of the events was unknown.
Patient received shot late afternoon or early evening on Wednesday.  She began to run a fever the following morning.  Her fever was 102 degrees from Thursday morning (24th) until Friday evening (25th).  She was felt achey, tired, and had a sore throat.  She began to feel much better by Sunday morning.
Case was hospitalized for pneumonia, SOB, Cough, Fever, and chills and had to be admitted to the ICU
Patient was supposed to receive the bivalent vaccine but received the monovalent vaccine instead- patient has been informed, no adverse outcomes at this time
8/6/2015 pt presents today with widespread hives/itching that he states started on Tues evening after his visit to clinic, where he received a Tdap. States rash started on his scalp, is now on his body, arms, legs. Has been taking BENADRYL 25 mg bid with some relief but cont to itch. Denies SOA, wheezing, chest tightness. 8/7/2015 ED PLAN: switch from BENADRYL to ATARAX: 25-50 mg 3 times a day. Also take prednisone 60 mg a day until rash is gone and then taper it off by 20 mg a day over a week. Add ZANTAC 300 mg a day if still having hives, and rub itching areas with 1% hydrocortisone cream whenever needed, instead of scratching. Ok to use Aveeno anti-itch products as well. Meds given in ED that day: 1253 epi 0.3mg IM given in Right deltoid and prednisone 60mg, BENADRYL 25mg and PEPCID 40mg po given. 1405 epi 0.3mg IM in left deltoid tolerated well. Patient was also seen that evening by local ED for difficulty breathing. 8/10/2015, PC visit. Rash and itching went away yesterday, but resumed today. Continue prednisone 60 mg x 1 wk, then start decreasing by 10 mg every 4 days continue hydroxyzine and ranitidine. 8/19/2015 ADDENDUM spoke with patient Allergic reaction has subsided, last dose of prednisone was yesterday 8/18. Allergy Consult appointment for 9-20-2015. Diphenhydramine 25 mg BID, dexamethasone 8 mg once, prednisone 60mg x 3, 40mgx3, 20mgx3.
weak; she had high fever 103 degree F temperature; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), PYREXIA (she had high fever 103 degree F temperature), HEADACHE (headache) and CHILLS (chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 12H21B) for COVID-19 vaccination.     Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced ASTHENIA (weak), PYREXIA (she had high fever 103 degree F temperature), HEADACHE (headache) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Fever, at a dose of 325 mg, 1 tablet. At the time of the report, ASTHENIA (weak), PYREXIA (she had high fever 103 degree F temperature), HEADACHE (headache) and CHILLS (chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Nov-2021, Body temperature: 103 (High) High fever 103 degree F temperature.         Patient reported that after 1st and 2nd dose, she already reported to Medical information that she was sick for 3 days, had high fever, headache and was weak.
Rash around injection site, knot in arm that moved towards elbow and red ring around elbow.
3 individuals exp sweating, chills, shoulder pain, back pain, h/a, earache, tinnitus, pain under ribs, abn liver funct tests, blurred vision, nausea/vomiting, diarrhea; This case is considered to be invalid;
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild
Received vaccine & the next day she felt light pressure in chest. ?Reflux. Liver functions elevated at ER
This spontaneous report as received from a other health professional refers to a female patient of unknown age. The patient was vaccinated with dose 2, 1 DF GARDASIL on NOV-2012 and dose 1, 1 DF on DEC-2012. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced inappropriate schedule. No treatment information was reported. The outcome of inappropriate schedule is unknown. Inappropriate schedule is not related to GARDASIL. No symptoms reported. No other details provided.
My doctor diagnosed as rapid heartrate atrial fib. I took 8 doses of blood pressure medication. It began with a hot flash 2 hours after my dose. I became extremely dizzy and experienced 185 heart rate, very elevated. It more or less subsided after about an hour. Since this happened I have not felt the same. I have been fatigued ever since.
This spontaneous report was received from a healthcare worker refers to a patient of unknown age and gender. No pertinent medical history was reported. On 04-JUN-2012, the patient was vaccinated with first dose of GARDASIL, 0.5 ml, intramuscular and the second dose on 10-JUL-2014. No adverse effects was reported. No Product Quality Complaint (PQC) was involved. Additional information has been requested.
Pain from her head to her toes. Especially her hips/ears. Increased blood pressure
Dizziness, ringing in ears, stated felt like passing out and fainted many times before with flu vaccine and blood drawing 63/45 12:25 81/57, 57, 16,  90/62 100% room air
speech difficulties (couldn't think of words, slurred words); Blurry eyesight; fever; clammy skin; headache; fatigue; itching skin; loss the ability to focus eyesight on phone, computer screen or books.; This is a spontaneous report from a Non-Contactable consumer (patient).  A 40-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EL3302), via unspecified route of administration in the Left arm, on 25May2021 at 10:30 AM, as a single for COVID-19 immunisation. Medical history included Hypothyroid. Concomitant medications included armour, liothyronine and spironolactone. The patient had no known allergies. On 25May2021 at 02:30 AM, the patient experienced Blurry eyesight, fever, clammy skin, headache, fatigue, itching skin, speech difficulties (could not think of words, slurred words), loss the ability to focus eyesight on phone, computer screen or books. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and Since the vaccination, the patient had not been tested for COVID-19. The patient was not tested for COVID-19 post vaccination. The patient did not received treatment for the events. The outcome of the events was recovered with lasting effects.  No follow-up attempts are possible. No further information is expected.
The patient states on 12/18/2020 at approximately 1430 a rash on both arms appeared.  The rash has lasted several weeks.  The rash continues to be present on 01/06/2020.  No itchiness.  Patient also states on 12/18/2020 at approximately 1700, she started with chills which got progressively worse throughout the evening, fever (99.8 F), patient states this temperature is 'high' for her, body aches, shortness of breath and a cough.  All these symptoms got worse enough where she thought she had to call 911.  However, the symptoms eventually subsided that night and she did not need to call 911.  The body aches, chills and "fever" lasted for about 2 days.
He started with a fever within 24 hrs of vaccination. Then he woke up with severe pain on his right side by his kidney. He vomited from the severe pain. I thought it was a kidney stone, but once he urinated the pain went away within several minutes. He has never had this before.
High fever over 104, lethargy, loose stool, vomiting. No rash. Fever lasted 3-4 days.
This case was reported by a physician via sales rep and described the occurrence of injection site pain in a patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain, fever and myalgia. On an unknown date, the outcome of the injection site pain, fever and myalgia were unknown. It was unknown if the reporter considered the injection site pain, fever and myalgia to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. The patient's current conditions and medical history were not provided. On 18-JAN-2016 the patient was inadvertently administered with an expired dose of M-M-R II (strength, dose, route, therapy type and indication not provided) of lot # J016234, expiration date: 19-DEC-2015. Concomitant medication was not mentioned. No adverse effects were reported. No additional information provided. Product quality complaint (PQC) was not involved. Additional information has been requested.
The second vaccine was a pneumococcal conjugate but the nurse failed to write down which form of the vaccine he received on his vaccine card.  Pt. was very fussy from the time we got back home and for the rest of the day. He ran a fever of 101 at 12:30pm for which I gave Tylenol and the fever returned at 6pm which I treated with Tylenol again. The only time he has stopped crying is when I can get him to nurse or when he can fall asleep for an hour or so. He is very restless and waking up frequently. It is now 9pm and he has fallen asleep in the bath with mom. We are unsure how the night will progress, but plan to monitor his fever closely.
Patient reports parosmia starting shortly after COVID vaccination in 1/2021. Of note, patient had history of COVID-19 infection in 10/2020. He was symptomatic with shortness of breath, malaise, myalgia, anosmia, and ageusia. However, all of the symptoms improved (including the anosmia and ageusia) by late 10/2020.
Injection site is swollen; Significant itching on the injection site; She may have chills; Injection site is red; Itching on her back and legs; Very little redness at the injection site; Very little pain; This spontaneous case was reported by a nurse and describes the occurrence of PRURITUS (Itching on her back and legs), INJECTION SITE ERYTHEMA (Very little redness at the injection site), INJECTION SITE PAIN (Very little pain), INJECTION SITE SWELLING (Injection site is swollen) and INJECTION SITE PRURITUS (Significant itching on the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. RB7K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced INJECTION SITE ERYTHEMA (Very little redness at the injection site) and INJECTION SITE PAIN (Very little pain). On 07-Jan-2021, the patient experienced PRURITUS (Itching on her back and legs), INJECTION SITE SWELLING (Injection site is swollen), INJECTION SITE PRURITUS (Significant itching on the injection site), CHILLS (She may have chills) and INJECTION SITE ERYTHEMA (Injection site is red). On 31-Dec-2020, INJECTION SITE ERYTHEMA (Very little redness at the injection site) and INJECTION SITE PAIN (Very little pain) had resolved. On 07-Jan-2021, PRURITUS (Itching on her back and legs), INJECTION SITE SWELLING (Injection site is swollen), INJECTION SITE PRURITUS (Significant itching on the injection site), CHILLS (She may have chills) and INJECTION SITE ERYTHEMA (Injection site is red) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
have not received the 2nd dose; face, tongue, and body went numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (face, tongue, and body went numb) and PRODUCT DOSE OMISSION ISSUE (have not received the 2nd dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergic reaction to bee sting and Allergic reaction to food (shrimp). Concomitant products included PROBIOTICS NOS for Gastrointestinal disorder NOS, GLA [GAMOLENIC ACID] for Supplementation therapy, LEVOTHYROXINE for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced HYPOAESTHESIA (face, tongue, and body went numb). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (have not received the 2nd dose). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse reaction, at a dose of 1 dosage form. In February 2021, HYPOAESTHESIA (face, tongue, and body went numb) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (have not received the 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that the patient also took unspecified fiber pills since 2016 for stomach issues concomitantly.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up information received on 07-Jul-2021 contains  significant information. Updated reporter information, added patient demographics, updated vaccination date, added facility information and concomitant levothyroxine.
Doctor cannot explain why antibody levels are so high; Fast heavy breathing; 15360.8 au/ml for antibody test and supposed to be lower than 50 to be normal.; sick; short of breath; very tired; Fast heavy breathing; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 56-year-old male patient received BNT162b2 (BNT162B2), on 18Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 56 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "chronic kidney stage 3" (unspecified if ongoing); "interchange of vaccine" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Corona vac (Dose 1, Anatomical location: Arm), administration date: May2021, for covid 19 immunization; Corona vac (dose 2, Anatomical location: Arm), administration date: Jun2021, for covid 19 immunization. The following information was reported: DYSPNOEA (non-serious) with onset 18Nov2021, outcome "unknown", RESPIRATORY RATE INCREASED (non-serious), outcome "unknown" and all described as "Fast heavy breathing"; FATIGUE (non-serious) with onset 18Nov2021, outcome "unknown", described as "very tired"; DYSPNOEA (non-serious), outcome "unknown", described as "short of breath"; BLOOD IMMUNOGLOBULIN G INCREASED (non-serious), outcome "unknown", described as "Doctor cannot explain why antibody levels are so high"; ANTIBODY TEST ABNORMAL (non-serious), outcome "unknown", described as "15360.8 au/ml for antibody test and supposed to be lower than 50 to be normal."; ILLNESS (non-serious), outcome "unknown", described as "sick". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Husband had two COVID-19 vaccines in another country. On 18Nov had Pfizer COVID-19 Vaccine, the booster was short of breath and very tired. Thought he was jet lagged. Then he had antibody test on 10Dec His IgG was 15,368 eu/mL and normal is less than 50. Not sure what is causing this issue He was totally fine He feels fine. Has kidney issues. Caller mentions something about he may have had kidney issues before. Doctor cannot explain why antibody levels are so high and recommended another test. Think patient might need a kidney transplant now Doctor wants patient to get another booster dose of COVID-19 Caller and patient are nervous because it was so bad Had another test at (company name) Antibody levels are still 4,000 Heard people who had COVID after a kidney transplant and it was pretty nasty    The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Redness at injection site. Area of redness is 9 cm X 10 cm, non infected. Treatment was to do cool compresses to affected area and may use Ibuprofen every 8 hr for next 48 hr.
First shot red, lumpy hot arm for 3 days. A week and half later I got pounding cluster headaches for 3 days.  Second shot I was exhausted and dehydrated the next day. 2 week later and until now I keep getting heart flutterings and chest pain that comes and goes.
Headache, nausea, dizziness, chills, fever, fatigue Narrative:
Hives on face, swollen face, bright red burning lips, swollen tongue, tingling feeling head to toes.
Devel chicken pox 1/27/2000. Examined w/in 24hrs w/ 100 leisons -papules on face, back, abd (2-4mm). Also in groin area, vesicles with red base (4-6mm). Slight cough, fever.
I received my booster on 12/4/21 at 4:20pm. I felt normal that day, woke up the next achy and by Sunday at 5pm it was hard to work or think- muscle and joint aches, cloudy brain, and intense irritability. I didn?t at all feel like myself mentally. Over the next few days my mental health took a nosedive. It felt like I was in a dark hole. It scared me and felt like nothing I have ever experienced. Physically, by Tuesday night (3 days post booster), I couldn?t lift a cup to take a drink of water without tears involuntarily falling: the whole aches were intense and severe. I sat still on the couch trying not move at all, but even being still the pain was horrible. By 5 days post vaccine I could move without deep pain, but still had whole body aches and muscle weakness. 6 days post vaccine I was able to not take ibuprofen for the first day, but still whole body aches. I am now almost 3 weeks post booster and continue to have whole body aches every day, muscle weakness to the point that it hurts walking up stairs. I am used to being strong and active and this is like a different life.
Covid Arm.  Red itching Rash (4.5 inches x 2.5 inches) around injection site appeared approximately six days after receiving vaccine.   At time of this reporting  it is 9 days after receiving vaccine and the rash is yet to subside.